Morgan E. Hresko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Morgan E. Hresko has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Leon Su
Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA
2 shared publications - Michael C. Milone
Center for Cellular Immunotherapies, 2 University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, USA
2 shared publications Alvin Yu
Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
1 shared publication- Carl H. June
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
1 shared publication - Charles-Antoine Assenmacher
University of Pennsylvania, Philadelphia, PA
1 shared publication Daniel E. Ryan
Biology and Chemistry, Agilent Technologies, Santa Clara, CA
1 shared publication
Latest Publications
- Open Access
- 14 November 2025
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 1 (3)
Viral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor
- 14 November 2025
- Published by Elsevier in Blood Immunology & Cellular Therapy
- Vol. 1 (3)
Open AccessViral vector-free generation of orthogonal IL-2–responsive CAR T cells through gene editing of IL-2 and its receptor
- 22 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (625) , eabg6986
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
A human IL-2 and IL-2Rβ orthogonal cytokine-receptor pair enables a tunable approach to enhancing CAR T cell engraftment and antitumor efficacy.
- 22 December 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (625) , eabg6986
A human orthogonal IL-2 and IL-2Rβ system enhances CAR T cell expansion and antitumor activity in a murine model of leukemia
A human IL-2 and IL-2Rβ orthogonal cytokine-receptor pair enables a tunable approach to enhancing CAR T cell engraftment and antitumor efficacy.